CSIMarket
 
Northern Technologies International Corporation  (NTIC)
Other Ticker:  
 
 



EARNINGS REPORT by CSIMarket

EPS Soar, Sales Lower

Northern Technologies International Corporation announced financial second quarter 2021 operating surplus of $1.767737 millions

Plastic_tubing_By_Paul_Goyette__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_CommonDespite soft demand in the financial second quarter 2021, company managed to increase it's earnings per share, earnings per share soared by 550 % to $0.13 per share while Sales fell by -3.41 % to $13 millions, year on year.

Looking into results from previous quarter Sales increased by 0.03 % from $13 millions and eps remained unchanged from $0.13 per share.

Net income of $1.503 millions in the financial second quarter 2021 increased by 429.72 % from break-even achieved in the corresponding quarter a year ago. Northern Technologies International Corporation also emphasized it's improving profit margins, where net margin rose to 11.76% in financial second quarter 2021, and operating margin edged up to 13.83%.


Northern Technologies International Corporation is expected to report next financial results on July 19, 2021.


    Recently Reported Results
grid-817366_960_720 Aterian Inc

Northern Technologies International Corporation announced financial second quarter 2021 operating surplus of $1.767737 millions

Despite soft demand in the financial second quarter 2021, company managed to increase it's earnings per share, earnings per share soared by 550 % to $0.13 per share while Sales fell by -3.41 % to $13 millions, year on year.

In contrast to the fourth quarter Sales improved by 16.01 % from $41.49 millions and increased losses from $-2.12 per share.

ATER stock quotes, charts, profile

Growth Rates, Profitability, PE

factory-2937337_960_720 Durable Goods Orders

U.S. Durable-goods orders dropped

Durable Goods orders fell after recent increases, but unfilled orders improved by 0.88 % to $1,082 billions.

welding_pd Helios Technologies Inc

Helios Technologies Inc announced first quarter of 2021 operating profit of $34.608 millions

Helios Technologies Inc announced earnings per share of $0.70 and Sales of $151.62 millions in the first quarter of 2021, Company's earnings turn positive per share, versus $-0.54 eps, earned in the same quarter a year ago, although Helios Technologies Inc saw its Sales rise by 58.2% in the same period.

In contrast to the fourth quarter Sales surged by 35.11 % from $151.62 millions and eps more than doubled by 304.97 % from $0.17 per share.

HLIO stock quotes, charts, profile

Growth Rates, Profitability, PE

pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Vaxcyte Inc

Vaxcyte Inc announced first quarter of 2021 operating shortfall of $-23.143 millions

In the first quarter of 2021 Vaxcyte Inc lost money of $-0.41 per share compared to $-3.02 a year ago and eps fell from $1.59 per share from the previous quarter.

Vaxcyte Inc reported operating loss of $-23.143 millions, in the first quarter of 2021, an improvement from the operating shortfall of $-89.581 millions, realized in first quarter of 2020

PCVX stock quotes, charts, profile

Growth Rates, Profitability, PE

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Syndax Pharmaceuticals Inc

Logged a Loss but Revenues Unchanged

In the first quarter of 2021 Syndax Pharmaceuticals Inc lost money of $-0.54 per share compared to $-0.56 a year ago and increased losses from $-0.44 per share from the previous quarter.

Sales remained unchanged by 0% to $0.38 millions from $0.38 millions in the same quarter a year ago and sequentially Sales decreased by -0.26% from $0.38 millions.

SNDX stock quotes, charts, profile

Growth Rates, Profitability, PE

Factory Orders (Picture Autor: Wolfgang Meinhart) licence GNU Factory Orders

U.S. Manufacturing orders dropped

Factory orders declined after recent increases, shipments deteriorated at the higher rate of -2.12 % to $502 billions.

dollar-1175048_960_720 Gross Domestic Product

Economy surges 6.4 % in the first-quarter

The U.S. Gross domestic product continued to grow at very solid pace during the January-through-March period,

factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

Industrial production rebounded in March

The output of the nation's factories progressed again after dipping in the last month, mainly because of higher production of durable goods.

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Beam Therapeutics Inc

Beam Therapeutics Inc announced fiscal time frame ending Mar 31 2021 operating deficit of $-200.373 millions

In the fiscal time frame ending Mar 31 2021 Beam Therapeutics Inc increased losses of $-3.35 per share compared to $-1.03 a year ago and increased losses from $-1.68 per share from the previous quarter.

Sales remained unchanged by 0% to $0.01 millions from $0.01 millions in the same quarter a year ago and sequentially Sales remained unchanged from $0.01 millions.

BEAM stock quotes, charts, profile

Growth Rates, Profitability, PE

dna-163466__340 Biodesix Inc

Biodesix Inc announced fiscal time frame ending Mar 31 2021 operating deficit of $-5.583 millions

Biodesix Inc announced very strong Sales growth of 481000% year on year to $28.87 millions in the fiscal time frame ending Mar 31 2021, but lost money at $-0.26.

compared to previous quarter eps fell from $0.62 per share and Revenue turn positive from $-9.19 millions.

BDSX stock quotes, charts, profile

Growth Rates, Profitability, PE

pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Otonomy Inc

Logged a Loss, Topline Crumbles

Otonomy Inc reported disappointing financial time frame ending Mar 31 2021, where Sales melted down by -43.75% to $0.09 millions and company posted loss per share to $-0.23, compared to $-0.38, in the same quarter a year ago.

compared to the previous quarter increased losses from $-0.20 per share and Sales surged by 69.81 % from $0.05 millions.

OTIC stock quotes, charts, profile

Growth Rates, Profitability, PE

tomography_pd Sientra inc

Company Fail to Break-even Despite Surge in Sales

Company increased losses at $-1.01 per share in the first quarter of 2021, although its Sales surged by 37.23% to $23.24 millions from the same quarter a year ago.

In the previous quarter company realized Sales of $22.64 millions and $-0.42 per share.

SIEN stock quotes, charts, profile

Growth Rates, Profitability, PE

Tomography_(CAT)_scan_pd Satsuma Pharmaceuticals Inc

Satsuma Pharmaceuticals Inc announced financial first quarter of 2021 operating shortfall of $-10.45 millions

In the financial first quarter of 2021 Satsuma Pharmaceuticals Inc decreased loss of $-0.48 per share compared to $-0.68 a year ago and improved from $-0.72 per share from the previous quarter.

Satsuma Pharmaceuticals Inc reported operating shortfall of $-10.45 millions, in the financial first quarter of 2021, an improvement from the operating shortfall of $-12.171 millions, realized in first quarter of 2020

STSA stock quotes, charts, profile

Growth Rates, Profitability, PE

Medical_ultrasound_examination_pd Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc announced first quarter of 2021 operating shortfall of $-16.059 millions

Company increased losses at $-0.42 per share in the first quarter of 2021, although its Sales surged by 30.91% to $4.36 millions from the same quarter a year ago.

In the previous quarter company realized Sales of $6.55 millions and $-0.25 per share.

XENE stock quotes, charts, profile

Growth Rates, Profitability, PE



Other NTIC's Earnings Reports

Northern Technologies International reported first quarter 2020 earnings

Northern Technologies International reported fourth quarter 2020 earnings

Northern Technologies International reported third quarter 2020 earnings

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FBK's Profile

Stock Price

FBK's Financials

Business Description

Fundamentals

Charts & Quotes

FBK's News

Suppliers

FBK's Competitors

Customers & Markets

Economic Indicators

FBK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071